info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

TIM3 Inhibitors Drug Market By Molecule Type (Monoclonal Antibodies, Small Molecules, Fusion Proteins, Bispecific Antibodies); By Indication (Solid Tumors, Hematologic Malignancies, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Academic Hospitals, Cancer Institutes, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TIM3 Inhibitors Drug Market is poised for notable expansion over the forecast period, with an CAGR of 16% between 2024 and 2030, The market is estimated t... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

GABA Receptor Agonist Market By Product Type (Benzodiazepine-Based Agonists, Barbiturates, Gabapentinoids, Allosteric Modulators); By Therapeutic Application (Epilepsy, Anxiety & Mood Disorders, Sleep Disorders, Spasticity, Neuropathic Pain); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global GABA Receptor Agonist Market will witness a robust CAGR of 6.8%, valued at USD 4.2 billion in 2024, exp... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Push-in Plug Vials Market By Material Type (Glass, Plastic); By Capacity (<5 ml, 5–20 ml, >20 ml); By Application (Parenteral Delivery, Oral Liquids, Clinical Sampling, Diagnostics, Compounding); By End User (Pharmaceutical Manufacturers, CDMOs, Compounding Pharmacies, Diagnostic Labs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Push-In Plug Vials Market is expected to grow steadily over the forecast period, with an CAGR of 5.8% , reaching an estimated market value of USD 734.6 million by 2030 fro... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Sterilization Tunnel Market By Technology Type (Dry Heat Sterilization Tunnels, Infrared Sterilization Tunnels); By Application (Pharmaceutical Manufacturing, Biotechnology, Food & Beverage); By End User (Large Pharmaceutical Companies, CDMOs, Biotech Firms, Food Producers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sterilization Tunnel Market is projected to expand steadily, valued at around USD 1.2 billion in 2024 and anticipated to reach approximately USD 1.9 billion by 203... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Antimalarial Drugs Market By Product Type (Artemisinin-based Combination Therapies, Chloroquine & Derivatives, Quinine & Alkaloids, Novel/Next-Gen Drugs); By Route of Administration (Oral, Parenteral, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Government & NGO Procurement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antimalarial Drugs Market will expand at an estimated CAGR of 6.3%, valued at around USD 4.1 billion in 2024, and projected to reach USD ... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Anti-Ageing Drugs Market By Drug Type (Senolytics, Metabolic Modulators, Hormonal Therapies, NAD+ Precursors, Antioxidants); By Route of Administration (Oral, Injectable, Transdermal); By Distribution Channel (Prescription Pharmacies, Retail Pharmacies & Wellness Clinics, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anti-Ageing Drugs Market is projected to grow at a CAGR of 8.6%, reaching approximately USD 28.9 billion by 2030, up from an estimated USD 17.5 bi... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Fragment Based Drug Discovery Market By Technique (X-ray Crystallography, NMR Spectroscopy, SPR, ITC, Others); By Service Type (Fragment Screening, Hit-to-Lead Optimization, Library Design, Custom Assays, Computational Modeling); By Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Autoimmune, Rare Disorders); By End User (Pharmaceutical Companies, Biotech Firms, Academic & Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fragment Based Drug Discovery Market will witness a strong CAGR of 14.5%, valued at USD 1.21 billion in 2024, and expected to reach USD 2.73 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Botulinum Toxin Market By Product Type (Botulinum Toxin Type A, Botulinum Toxin Type B); By Application (Aesthetic, Therapeutic – Neurology, Urology, Gastroenterology, Pain, Others); By End User (Hospitals, Specialty Clinics, Aesthetic Centers, Ambulatory Surgical Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Botulinum Toxin Market is expected to grow steadily at a CAGR of 7.8%, reaching approximately USD 11.2 billion in 2024, and projected to cross USD... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Drug Bioavailability Enhancement Market By Product Type (Solubility Enhancers, Permeability Enhancers, Metabolism Modifiers); By Route of Administration (Oral, Transdermal, Nasal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Bioavailability Enhancement Market is projected to expand at a CAGR of 8.6%, growing from USD 4.9 billion in 2024 to USD 8.1 billion by 2030, accordi... Read More

Published Date: DEC-2025 | No Of Pages:158 | $ 4485

SARM1 Inhibitors Market By Application (ALS, Peripheral Neuropathies, Traumatic Brain & Spinal Cord Injuries, MS, Chemotherapy-Induced Neuropathy, Others); By Molecule Type (Small Molecule Inhibitors, Biologics & Peptides, Gene & RNA-based Approaches); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global SARM1 Inhibitors Market is projected to expand rapidly, growing at an inferred CAGR of 28.5% from 2024 to 2030, valued at roughly USD 120 million ... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Injection Bottle Market By Product Type (Sterile Injection Bottles, Non-Sterile Injection Bottles); By Material (Glass, Polymer); By Capacity (<10 ml, 10–50 ml, >50 ml); By End User (Pharmaceutical Companies, CMOs, Hospitals, Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Injection Bottle Market will witness a steady CAGR of 5.8%, valued at USD 9.7 billion in 2024, expected to expand and reach USD 13.6 billion by 2030, acco... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Orphan Drugs Market By Drug Type (Biologics, Non-Biologics); By Therapy Area (Oncology, Neurology, Metabolic & Endocrine Disorders, Others); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orphan Drugs Market will witness a steady CAGR of 9.6% , valued at USD 175.2 billion in 2024 , expected to appreciate and reach nearly USD 305.4 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Ticagrelor Market By Product Type (Branded, Generic); By Indication (Acute Coronary Syndrome, Myocardial Infarction Prevention, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ticagrelor Market is projected to expand steadily between 2024 and 2030, growing at a CAGR of 6.1% , valued at around USD 2.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Psychedelic Drugs Market By Drug Type (Psilocybin, MDMA, Ketamine, LSD & Others); By Application (Depression, PTSD, Addiction, Anxiety); By Distribution Model (Clinic-Based Therapy, Hospital Pharmacies, Home Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Psychedelic Drugs Market is projected to expand steadily between 2024 and 2030, with an CAGR of 13.5% , valued at around USD 5.1 billion in 2024 and expec... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Ophthalmic Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV); By Study Design (Interventional, Observational, Adaptive/Hybrid); By Indication (Age-Related Macular Degeneration, Glaucoma, Diabetic Retinopathy, Dry Eye, Rare Retinal Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmic Clinical Trials Market is projected to expand steadily between 2024 and 2030, with demand fueled by rising cases of glaucoma, age-related macular degeneration (AMD), diabetic re... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Therapeutic Vaccines Market By Disease Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Neurological Conditions); By Technology (Dendritic Cell Vaccines, Tumor Cell Vaccines, DNA-based Vaccines, mRNA Vaccines, Viral Vector Vaccines, Protein/Peptide Vaccines); By Route of Administration (Intramuscular, Subcutaneous, Intradermal, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Therapeutic Vaccines Market will expand steadily between 2024 and 2030, with CAGR of 7.8% , valued at approximately USD 21.6 billion in 2024 and expe... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Anti-CD47 Drugs Market By Drug Type (Monoclonal Antibodies, Bispecific Antibodies, Fusion Proteins, Small Molecules); By Application (Hematologic Malignancies, Solid Tumors); By End User (Academic Cancer Centers, Oncology Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anti- CD47 Drugs Market is expected to witness a strong compound annual growth rate (CAGR) of 38.5%, with an estimated market value of USD 0.56 bi... Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

RSV Vaccine Market By Vaccine Type (Subunit Vaccines, Live-Attenuated Vaccines, mRNA Vaccines); By Target Population (Older Adults, Pregnant Women, Infants & Children, Immunocompromised Individuals); By Route of Administration (Intramuscular, Intranasal); By Distribution Channel (Hospital Pharmacies, Retail Clinics, Public Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RSV Vaccine Market will witness a robust CAGR of 15.6% , valued at USD 2.1 billion in 2024 , and expected to reach USD 5.0 billio... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

PCSK9 Inhibitor Market By Drug Type (Monoclonal Antibodies, siRNA Therapies); By Indication (ASCVD, Familial Hypercholesterolemia, Statin Intolerance); By Route of Administration (Subcutaneous Injection, Long-Interval Injection); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PCSK9 Inhibitor Market is poised for steady expansion, with an inferred valuation of $5.1 billion in 2024 and projected to reach approximately Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Drug Reconstitution Market By Product Type (Vials with Diluent, Dual-Chamber Systems, Prefilled Syringes); By Drug Class (Biologics, Vaccines & Immunoglobulins, Antibiotics & Antifungals); By End User (Hospitals, Clinics & Specialty Practices, Home Healthcare, CDMOs/Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Reconstitution Market will witness a steady CAGR of 6.1%, valued at USD 3.7 billion in 2024 , and expected to reach USD 5.3 billion by 2030 , accordi... Read More

Published Date: DEC-2025 | No Of Pages:194 | $ 4485

Growth Hormone Deficiency Market By Therapy Type (Daily Recombinant Growth Hormone, Long-Acting Growth Hormone); By Patient Group (Pediatric Growth Hormone Deficiency, Adult Growth Hormone Deficiency); By Route of Administration (Subcutaneous Injection, Smart Pen/Connected Devices); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Growth Hormone Deficiency Market is projected to expand at a steady CAGR of 6.3% , reaching USD 7.6 billion by 2030 , up from an estimated USD 5.2 billion in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Brain Tumor Drugs Market By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy, Corticosteroids); By Tumor Type (Glioblastoma, Astrocytoma, Medulloblastoma, Pituitary Tumors, Others); By Route of Administration (Oral, Injectable, Implantable); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brain Tumor Drugs Market will witness a solid CAGR of 8.5%, valued at USD 3.6 billion in 2024 and projected to reach Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

TIGIT Inhibitors Market By Therapy Type (Monotherapy, Combination Therapy); By Cancer Indication (NSCLC, Triple-Negative Breast Cancer, Melanoma, Head & Neck Cancer, Others); By Route of Administration (Intravenous, Others); By End User (Academic Cancer Centers, Oncology Clinics, CROs, Specialty Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TIGIT Inhibitors Market will witness a strong CAGR of 22.6%, valued at $0.42 billion in 2024 , expected to appreciate and reach $... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Cytotoxic Drugs and HPAPI Manufacturing Market By Product Type (Cytotoxic Drugs, HPAPIs); By Application (Oncology, Autoimmune Disorders, Others); By Manufacturing Approach (In-House Manufacturing, Outsourced Manufacturing); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cytotoxic Drugs and HPAPI Manufacturing Market is projected to grow at a CAGR of 8.6% , valued at USD 21.7 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Complement Inhibitors Market By Product Type (Monoclonal Antibodies, Small Molecules, RNA-based Therapies, Others); By Indication (Hematology, Nephrology, Neurology, Ophthalmology, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online/Direct Distribution); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Complement Inhibitors Market will witness a steady CAGR of 9.8% , valued at USD 8.6 billion in 2024 and projected to reach USD 15.1 billion by 2030 , acco... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

EZH2 Inhibitors Market By Drug Type (Tazemetostat, CPI-1205, Valemetostat, Others); By Indication (Follicular Lymphoma, Epithelioid Sarcoma, Prostate Cancer, Others); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global EZH2 Inhibitors Market is projected to expand at a strong CAGR of 17.9%, valued at approximately USD 815.2 million in 2024 , and expected... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Antiemetics Drugs Market By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Dopamine Antagonists, Cannabinoids & Others); By Application (Chemotherapy-Induced Nausea and Vomiting, Post-Operative Nausea and Vomiting, Motion Sickness & Gastroenteritis, Pregnancy-Induced Nausea); By Route of Administration (Oral, Injectable, Transdermal & Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiemetics Drugs Market is projected to expand steadily between 2024 and 2030. The market is valued at USD 6.8 billion in 2024 and is expected to reach <... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Pulmonary Arterial Hypertension Market By Drug Class (Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase-5 Inhibitors, Soluble Guanylate Cyclase Stimulators, Emerging Therapies); By Route of Administration (Oral, Injectable, Inhaled); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Arterial Hypertension (PAH) Market is projected to grow steadily between 2024 and 2030 , moving from an estimated USD 8.7 billion in 2024 to app... Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Specialty Generics Market By Product Type (Injectables, Oral Modified-Release Formulations, Inhalable Generics, Ophthalmic Generics, Others); By Therapeutic Area (Oncology, Autoimmune Disorders, Cardiology & Respiratory, Neurology, Others); By Route of Administration (Injectable, Oral, Inhalation, Topical & Ophthalmic); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Specialty Generics Market is projected to expand steadily, registering a CAGR of 8.1% , with an estimated valuation of USD 75.6 billion in 2024 and expected to reach Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Tramadol Market By Product Type (Immediate-Release, Extended-Release, Injectable, Combination Drugs); By Application (Orthopedic Pain, Cancer Pain, Post-Surgical Pain, Neuropathic Pain); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tramadol Market will expand at a CAGR of 6.5%, valued at USD 2.4 billion in 2024, and expected to reach USD 3.50... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Bevacizumab Biosimilars Market By Indication (Colorectal Cancer, Lung Cancer, Renal Cell Carcinoma, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online & Retail Pharmacies); By End User (Large Hospitals & Cancer Institutes, Community Oncology Clinics, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bevacizumab Biosimilars Market will witness a robust CAGR of around 17.0 %, valued at approximately USD 3.6 billion in 2024, expected to ... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Wound Gel Market By Product Type (Hydrogel-Based, Antimicrobial, Alginate-Based, Collagen-Based); By Wound Type (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Surgical Wounds, Burns, Traumatic Wounds); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Wound Gel Market will witness a steady CAGR of 6.2% , valued at $1.58 billion in 2024 , and projected to reach around $2.26 billion by 2030, according to ... Read More

Published Date: DEC-2025 | No Of Pages:158 | $ 4485

Hyaluronidase Market By Product Type (Animal-Derived, Recombinant); By Route of Administration (Subcutaneous, Intravenous, Topical); By Application (Aesthetic Procedures, Oncology, Ophthalmology, Orthopedics, Drug Delivery); By End User (Hospitals, Specialty Clinics, Cosmetic Dermatology Centers, Research Labs, Biopharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyaluronidase Market is projected to expand steadily between 2024 and 2030, advancing at a CAGR of 7.8% , with revenues reaching approximately USD... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Contraceptive Drugs Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives, Emergency Contraceptives, Other Hormonal Therapies); By Route of Administration (Oral, Injectable, Transdermal & Vaginal, Implants & IUS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Family Planning Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Contraceptive Drugs Market will expand at a steady pace between 2024 and 2030, with an estimated value of USD 16.9 billion in 2024 and projected to reach around US... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Dental Cleansing Tablet Market By Product Type (Standard Effervescent Tablets, Multi-Action Tablets, Natural and Eco-Friendly Tablets); By Application (Dentures, Orthodontic Aligners & Retainers, Sports Mouthguards & Sleep Appliances); By Distribution Channel (Retail Pharmacies, Online/E-commerce, Supermarkets & General Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dental Cleansing Tablet Market will witness a robust CAGR of 6.8%, valued at USD 3.2 billion in 2024 , expected to appreciate and reach USD 4.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:176 | $ 4485

Vyvgart (Efgartigimod) Market By Indication (gMG, CIDP, ITP, Pemphigus Vulgaris & Foliaceus, Myositis, Nephrology Disorders); By Route of Administration (Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Outpatient Clinics, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vyvgart (Efgartigimod) Market is projected to grow at a CAGR of 32.8% , reaching approximately USD 6.1 billion b... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Pharmaceutical Isolator Market By Type (Open Isolators, Closed Isolators, Modular & Robotic Isolators); By Application (Sterile Manufacturing, Research & Development, Quality Control & Testing, Cytotoxic & HPAPI Handling); By End User (Pharmaceutical & Biotechnology Companies, CDMOs, Academic & Research Institutes, Hospitals & Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Isolator Market is forecast to expand steadily between 2024 and 2030. Based on industry indicators and inferred estimates, the market is valued at USD 6.2 billion in 2024 an... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Small Molecule CDMO Market By Service Type (API Development & Manufacturing, Drug Product Formulation, Packaging Services); By Molecule Type (Innovative Small Molecules, Generic Small Molecules); By Phase of Development (Early-Phase Development, Late-Phase and Commercial Manufacturing); By End User (Large Pharmaceutical Companies, Mid-Sized Pharma, Emerging Biotech, Generic & Specialty Pharma); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule CDMO Market is poised for steady expansion between 2024 and 2030. The market is valued at approximately USD 67.5 billion in 2024 and is pro... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Drug Discovery Outsourcing Market By Service Type (Preclinical Services, Clinical Trials Services, Discovery Chemistry & Biology Services, Regulatory and Clinical Development Services); By Therapeutic Area (Oncology, Neurology, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical Companies, Biotechnology Firms, Academic & Research Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Discovery Outsourcing Market is projected to grow significantly from USD 9.4 billion in 2024, with an expected CAGR of 7.2% until 2030 , reaching USD 14.3 bil... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Artificial Tears Market By Product Type (Preservative-Free, Gel-Based, Traditional); By Distribution Channel (Retail Pharmacies, Online, Hospitals and Clinics); By End User (Individuals with Dry Eye Disease, Healthcare Providers, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Tears Market is expected to grow significantly, with an estimated value of USD 4.5 billion in 2024, projected to reach USD 7.63 billion by 2030, reflecting a Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Dry Powder Inhaler Market By Product Type (Single-Dose Inhalers, Multi-Dose Inhalers, Pre-filled Inhalers); By Application (Asthma, COPD, Other Pulmonary Diseases); By End User (Hospitals, Clinics, Homecare, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dry Powder Inhaler Market will witness a substantial growth trajectory, driven by the increasing prevalence of chronic respiratory conditions such as asthma, chronic obstructive pulmonary ... Read More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

Small Molecule Drug Discovery Market By Drug Type (Targeted Therapy Drugs, Chemotherapy Drugs, Other Small Molecules); By Disease Area (Oncology, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Metabolic Disorders); By Stage of Development (Preclinical, Clinical Development, Commercialized Products); By End User (Pharmaceutical Companies, Biotechnology Firms, CROs, Academic and Research Institutions, Hospitals and Healthcare Providers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule Drug Discovery Market is positioned for substantial growth, with an expected compound annual growth rate (CAGR) of 9.4 % from 2024 to 2030. The market is pr... Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Cold Form Blister Packaging Market By Material Type (Aluminum Foil, PVC, Polyamide); By Application (Prescription Pharmaceuticals, OTC Drugs & Supplements, Diagnostic Kits, Others); By End User (Pharmaceutical Manufacturers, Nutraceutical Brands, Diagnostic Kit Makers, Contract Packaging Organizations); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cold Form Blister Packaging Market is set to grow at a CAGR of 6.2% , reaching approximately USD 8.6 billion by 2030 , up from an estimated USD 5.... Read More

Published Date: NOV-2025 | No Of Pages:154 | $ 4485

Plant-Based API Market By Product Type (Herbal APIs, Botanical APIs); By Application (Cardiovascular Diseases, Diabetes, Oncology, Metabolic Disorders, Others); By End-User (Pharmaceutical & Biotech Companies, CROs, Academic & Research Institutions, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Plant-Based API Market is poised for robust growth, driven by the increasing demand for natural and sustainable alternatives in pharmaceuticals. Valued at USD 4.2 ... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

3D Printed Drugs Market By Technology (Fused Deposition Modeling, Inkjet Printing, Stereolithography); By Application (Personalized Medicine, On-Demand Drug Manufacturing, Oral Solid Dosage Development); By End User (Pharmaceutical & Biotech Companies, Academic & Research Institutions, Hospitals & Compounding Pharmacies, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global 3D Printed Drugs Market will witness an exceptional CAGR of 16.2% , valued at $410 million in 2024, expected to surge and reach $... Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Generic Oncology Drugs Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy); By Cancer Type (Breast, Lung, Colorectal, Leukemia, Lymphoma, Others); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Generic Oncology Drugs Market will experience robust growth from 2024 to 2030, expected to expand at a CAGR of 6.07%, valued at USD 26.07... Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Cannabis Testing Market By Testing Type (Potency Testing, Contaminant Testing, Terpene Testing, Residual Solvent Testing); By Methodology (Chromatography, Mass Spectrometry, Immunoassays); By End-User (Cannabis Producers, Dispensaries, Research Organizations, Government & Regulatory Bodies, Consumers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Testing Market is poised for steady growth from 2024 to 2030, driven by increasing regulatory frameworks, a growing need for product safety, and rising consumer demand for high-qu... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Lyophilized Injectable Drugs Market By Product Type (Biologics, Chemotherapeutic Drugs, Hormones, Other Injectable Drugs); By Application (Oncology, Infectious Diseases, Endocrinology, Other Therapeutic Areas); By End User (Pharmaceutical & Biotech Companies, Contract Manufacturing Organizations, Hospitals & Clinics, Research Institutions); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lyophilized Injectable Drugs Market is expected to see substantial growth from 2024 to 2030 , with a projected CAGR of 8.5% . The market was valued at Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Prefilled Formalin Vials Market By Product Type (Single-Use Prefilled Vials, Reusable Prefilled Vials); By Application (Medical & Clinical Diagnostics, Forensic Science, Research & Development); By End User (Hospitals & Healthcare Providers, Research Institutes & Laboratories, Contract Research Organizations, Forensic Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Prefilled Formalin Vials Market will witness a robust CAGR of 6.5% , valued at USD 400 million in 2024 , and is projected to reach approximately USD 600 million by 2030Read More

Published Date: NOV-2025 | No Of Pages:161 | $ 4485

Cyclooxygenase-2 (COX-2) Inhibitor Market By Product Type (Prescription, OTC); By Application (Osteoarthritis, Rheumatoid Arthritis, Acute Pain, Other Inflammatory Diseases); By End User (Pharmaceutical Companies, Hospitals, Retail Pharmacies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclooxygenase -2 (COX -2) Inhibitor Market is projected to grow steadily, with a CAGR of 4.2% , valued at USD ... Read More

Published Date: NOV-2025 | No Of Pages:170 | $ 4485

Softgel Capsules Market By Product Type (Standard Softgel Capsules, Specialty Softgel Capsules); By Application (Pharmaceuticals, Nutraceuticals, Cosmetics and Personal Care); By End User (Pharmaceutical Companies, Nutraceutical Companies, CMOs, Cosmetics and Personal Care Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Globa l Softgel Capsules Market is poised for steady growth, with a CAGR of approximately 7.5 % , valued at USDRead More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Enteric Softgel Capsules Market By Product Type (Gelatin-Based, Vegetable-Based); By Application (Pharmaceuticals, Nutraceuticals, Cosmetics); By End User (Pharmaceutical Companies, Nutraceutical Companies, CROs, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Enteric Softgel Capsules Market is expected to experience steady growth, with a projected CAGR of 6.2% from 2024 to 2030, rising from a v... Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Oral and Topical Anaesthetics Market By Product Type (Oral Anaesthetics, Topical Anaesthetics); By Application (Dental Procedures, Dermatology, Emergency Medicine, Other Applications); By End User (Dental Clinics, Dermatology Clinics, Hospitals, OTC Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oral and Topical Anaesthetics Market is set to experience notable growth in the coming years, with a projected CAGR of 5.8% from 2024 to 2030. In Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Coccidioidomycosis Market By Treatment Type (Antifungal Drugs, Vaccines); By Diagnostic Method (PCR, Serology, Imaging); By End-User (Hospitals, Pharmaceutical Companies, Research Institutes); By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Coccidioidomycosis Market is on a steady upward trajectory, driven by the increasing recognition of the disease’s burden, the growing need for effective treatments, ... Read More

Published Date: NOV-2025 | No Of Pages:199 | $ 4485

Pharmaceutical Grade Lactose Market By Product Type (Anhydrous Lactose, Monohydrate Lactose); By Application (Oral Solid Dosage Forms, Inhalation Drugs, Others); By End User (Pharmaceutical Manufacturers, CROs, Generic Drug Manufacturers, Academic & Research Institutions, Forensic & Environmental Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Grade Lactose Market is projected to witness steady growth, with a compound annual growth rate (CAGR) of 4.2% , valued at USD 2.3 b... Read More

Published Date: NOV-2025 | No Of Pages:200 | $ 4485

Rapid Acting Insulin Market By Product Type (Branded Insulin, Generic Insulin); By Administration Route (Injection Pens, Insulin Pumps, Others); By End-User (Hospitals, Home Care Settings, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rapid Acting Insulin Market will experience steady growth, with an expected CAGR of 6.5% , valued at USD 16.5 billion in 2024 , and projected to reach USD 24.5 bi... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Chondroitin Sulfate Market By Source Type (Bovine, Shark, Porcine, Plant-Based); By Application (Dietary Supplements, Pharmaceuticals, Veterinary Medicine, Cosmetics); By End User (Consumers, Healthcare Providers, Veterinary Clinics, Cosmetic Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondroitin Sulfate Market is poised for steady growth, driven by the increasing demand for joint health supplements and the expanding therapeutic applications of chondroi... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

Albumin Market By Product Type (Human Albumin, Recombinant Albumin); By Application (Plasma Volume Expanders, Drug Delivery Systems, Diagnostic Reagents); By End User (Hospitals, Pharmaceutical & Biotech Companies, Research Laboratories, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Albumin Market is poised for significant growth, with a projected Compound Annual Growth Rate (CAGR) of 7.5% from 2024 to 2030, reaching a market value of $8.7 bil... Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Throat Lozenges Market By Product Type (Medicated, Non-Medicated); By Active Ingredients (Menthol, Honey & Herbal Extracts, Others); By Distribution Channel (Pharmacies & Drug Stores, Online Retail, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Throat Lozenges Market will experience steady growth during the forecast period from 2024 to 2030, with a projected CAGR of 5.6 % , estimated to reach a market value of Read More

Published Date: NOV-2025 | No Of Pages:172 | $ 4485

Anti-Infective Agents Market By Product Type (Antibiotics, Antivirals, Antifungals, Antiparasitic Drugs); By Therapeutic Class (Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, HIV Antivirals, Antimalarial Agents, Antifungal Agents); By Infection Type (Respiratory, Urinary Tract, Gastrointestinal, Skin, STIs, Others); By End-User (Hospitals, Clinics, Long-Term Care Facilities, Pharmaceutical Companies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anti-Infective Agents Market will experience significant growth from USD 82.3 billion in 2024 to approximately USD 120.5 billion by 2030 , driven by a rob... Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Skin Barrier Market By Product Type (Wipes & Films, Creams & Ointments, Sprays & Liquid Barriers); By Application (Ostomy Care, Wound Care, Incontinence Management, Dermatological Conditions); By End User (Hospitals & Clinics, Home Healthcare, Nursing Homes, Retail Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Skin Barrier Market will witness a steady CAGR of 6.64 % , valued at around USD 1.4 billion in 2024 , and is forecast to reach USD 2.1 billion by ... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Chromatography Accessories and Consumables Market By Product Type (Columns, Syringe Filters, Vials and Caps, Reagents and Solvents, Tubing and Fittings); By Chromatography Technique (Liquid Chromatography, Gas Chromatography, Thin Layer Chromatography, Ion Chromatography); By End User (Pharmaceutical and Biotech Companies, CROs and CDMOs, Environmental Labs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chromatography Accessories And Consumables Market will witness a steady CAGR of 5.9% , valued at $5.4 billion in 2024 , ... Read More

Published Date: NOV-2025 | No Of Pages:153 | $ 4485

Long-Acting Insulin Market By Product Type (Insulin Glargine, Insulin Detemir, Insulin Degludec, Others); By Application (Type 1 Diabetes, Type 2 Diabetes); By End User (Hospitals, Clinics, Home Care Settings, Diabetes Care Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long - Acting Insulin Market is poised for substantial growth, driven by the increasing prevalence of diabetes and advancements in insulin delivery techno... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Antibody-mediated Rejection Prevention Market by Product Type (Monoclonal Antibodies, Plasma Exchange Therapies, Gene Therapies, Other Biological Agents); By Application (Kidney Transplants, Heart Transplants, Liver Transplants, Lung Transplants); By End User (Hospitals & Transplant Centers, Contract Research Organizations, Pharmaceutical Companies, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Antibody-mediated Rejection Prevention Market is poised for significant growth in the coming years. In 2024, the global market will be valued at USD 1.5 billion , with projections indicating it w... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Submucosal Lifting Agent Market By Product Type (Synthetic Agents, Natural Agents); By Application (Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, Polypectomy Assistance); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Endoscopy Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Submucosal Lifting Agent Market is projected to expand at a CAGR of 7.3% , climbing from an estimated $145 million in 2024 to reach $222 million by 2030 ,... Read More

Published Date: NOV-2025 | No Of Pages:179 | $ 4485

Hemostatic Gels Market By Product Type (Active Hemostatic Gels, Passive Hemostatic Gels); By Application (Surgical Wound Management, Trauma & Emergency Care, Dental Procedures, Neurosurgery); By End User (Hospitals, Ambulatory Surgical Centers, Military & Emergency Response Units, Dental Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemostatic Gels Market is projected to expand at a CAGR of 6.4% , reaching $1.62 billion by 2030 , up from an estimated $1.1 bill... Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

Progesterone Market By Product Type (Oral Tablets, Injectables, Topical Preparations); By Application (Infertility Treatment, Hormone Replacement Therapy, Other Applications); By End User (Fertility Clinics, Hospitals, Pharmaceutical Companies, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Progesterone Market is expected to experience steady growth, with a projected CAGR of 6.3% , expanding from a market size of $4.6 billion in 2024 to $7.2 billion b... Read More

Published Date: NOV-2025 | No Of Pages:195 | $ 4485

CIS Insulin Market By Product Type (Human Insulin, Insulin Analogs [Basal, Prandial, Premixed]); By Route of Administration (Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The CIS Insulin Market will witness a robust CAGR of 6.43% , valued at USD 1.2 billion in 2024, expected to appreciate and reach USD 1.68 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Meningococcal Vaccines Market By Vaccine Type (Polysaccharide, Conjugate, Recombinant Protein-Based); By Serogroup Coverage (Monovalent, Bivalent, Quadrivalent, Pentavalent); By Distribution Channel (Public Health Agencies, Hospital Pharmacies, Retail Clinics); By End User (Hospitals, Pediatric Clinics, Military, Travel Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meningococcal Vaccines Market will witness a robust CAGR of 8.4% , valued at $4.7 billion in 2024 , and is expected to appreciate and reach around $7.6 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Respiratory Syncytial Virus (RSV) Vaccine Market By Vaccine Type (Live Attenuated Vaccines, Subunit Vaccines, mRNA Vaccines, Vector-Based Vaccines, Others); By Target Population (Infants, Older Adults, Pregnant Women, High-Risk Adults, Others); By Route of Administration (Intramuscular, Intranasal, Subcutaneous, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Respiratory Syncytial Virus (RSV) Vaccine Market will witness a robust CAGR of 17.3% , valued at $2.4 billion in 2024 , and is expec... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Cancer Vaccines Market By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines); By Disease Indication (Cervical Cancer, Prostate Cancer, Others); By End-User (Hospitals and Clinics, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Vaccines Market is set to experience a robust growth trajectory from 2024 to 2030 , driven by increased research and development activities, advancements in biotech... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485

Influenza Vaccine Market By Vaccine Type (Inactivated, Recombinant, Live Attenuated); By Age Group (Adults, Children, Elderly); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Influenza Vaccine Market will witness a robust CAGR of 5.1% , valued at $6.3 billion in 2024 , and is expected to appreciate to $8.9 billion by 2030 , con... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Carbapenem Market By Product Type (Meropenem, Imipenem-Cilastatin, Ertapenem, Doripenem, Others); By Indication (Respiratory Infections, UTIs, Intra-abdominal Infections, Sepsis, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carbapenem Market will witness a robust CAGR of 5.8% , valued at USD 3.62 billion in 2024 , expected to appreciate and reach USD 5.07 billion by 2030 , co... Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Anti-emetic Drugs Market By Drug Type (Serotonin Antagonists, NK1 Antagonists, Dopamine Antagonists, Corticosteroids); By Route of Administration (Oral, Intravenous, Transdermal); By End-User (Hospitals, Clinics, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antiemetic Drugs Market will witness a robust CAGR of 5.2% , valued at $8.5 billion in 2024, expected to appreciate and reach $12.5 billionRead More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485

Subcutaneous Immunoglobulin Market By Product Type (Standard SCIG, High-Concentration SCIG); By Indication (Primary Immunodeficiency Diseases, Secondary Immunodeficiencies, Neurological Disorders, Other Autoimmune Disorders); By End User (Homecare Settings, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Subcutaneous Immunoglobulin (SCIG) Market will witness a robust CAGR of 8.9% , valued at approximately $6.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485

Shingles Vaccine Market By Vaccine Type (Recombinant Subunit, Live Attenuated); By Route of Administration (Intramuscular, Subcutaneous); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Public Health Agencies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Shingles Vaccine Market will witness a robust CAGR of 8.6% , valued at approximately $4.2 billion in 2024 , and is expected to appreciate and reach nearly $7.0 bil... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Medical Cannabis Market By Product Type (Flowers, Oils & Tinctures, Capsules, Edibles, Topicals); By Application (Chronic Pain, Neurology, Oncology, Mental Health Disorders, Others); By Route of Administration (Inhalation, Oral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Medical Cannabis Market will witness a robust CAGR of 16.9% , valued at USD 21.3 billion in 2024, expected to appreciate and reach USD 54.7 billio... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Biopharmaceutical Excipients Market By Product Type (Binders, Preservatives, Stabilizers, Emulsifiers, Solvents); By Application (Injectable Formulations, Oral Drug Formulations, Vaccines); By End User (Pharmaceutical Manufacturers, Contract Manufacturing Organizations [CMOs], Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biopharmaceutical Excipients Market will experience a solid growth trajectory from USD 7.8 billion in 2024 to USD 11.5 billion by 2030 , reflecting a robust CAGR o... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485

Cannabis Extract Market By Extract Type (Full Spectrum, Broad Spectrum, Isolates); By Application (Pharmaceuticals, Food & Beverages, Personal Care, Recreational Use); By End User (Medical Users, Adult-Use Consumers, Industrial Buyers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Extract Market will witness a robust CAGR of 18.6% , valued at $12.4 billion in 2024, expected to appreciate and reach $34.2 billionRead More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Alpha Glucosidase Inhibitors Market By Drug Type (Acarbose, Miglitol, Voglibose, Others); By Indication (Type 2 Diabetes Mellitus, Prediabetes, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Glucosidase Inhibitors Market will witness a robust CAGR of 8.1% , valued at $1.32 billion in 2024 , expected to appreciate and reach $2.11 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Bronchodilators Market By Drug Class (Beta-2 Adrenergic Agonists, Anticholinergics, Theophylline, Combination Therapies); By Route of Administration (Inhalation, Oral, Injectable); By Indication (Asthma, Chronic Obstructive Pulmonary Disease, Others); By End User (Hospitals, Retail Pharmacies, Homecare Settings, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bronchodilators Market will witness a robust CAGR of 6.7 % , valued at $17.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Sustained Release Excipients Market By Product Type (Polymers [Natural, Synthetic], Coatings [Functional, Osmotic], Minerals, Gums & Lipids); By Formulation Type (Oral Tablets, Capsules, Injectables, Implants); By Route of Administration (Oral, Parenteral, Transdermal, Others); By End User (Pharmaceutical Companies, CMOs, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sustained Release Excipients Market will witness a robust CAGR of 7.1% , valued at $2.97 billion in 2024 , and is expected to appreciate and reach $4.79 billion by... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

OTC Dry Eye Drops Market By Product Type (Artificial Tears, Lubricant Eye Drops, Gel Drops, Specialty Formulations); By Formulation (Preservative-Free, With Preservatives); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies & E-commerce, Supermarkets/Hypermarkets); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global OTC Dry Eye Drops Market will witness a robust CAGR of 6.8% , valued at USD 3.42 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Muscle Relaxant Drugs Market By Drug Class (Centrally Acting Skeletal Muscle Relaxants, Direct-Acting Muscle Relaxants); By Route of Administration (Oral, Injectable); By Application (Musculoskeletal Conditions, Neurological Disorders, Perioperative and ICU Care); By End User (Hospitals, Outpatient Clinics, Rehabilitation Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Muscle Relaxant Drugs Market will witness a robust CAGR of 5.8% , valued at $2.34 billion in 2024, expected to appreciate and reach $3.29 billion by 2030,... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Alpha Emitter Market By Isotope Type (Actinium-225, Radium-223, Astatine-211, Lead-212, Others); By Application (Prostate Cancer, Bone Metastases, Leukemia & Lymphoma, Neuroendocrine Tumors, Others); By End User (Hospitals & Oncology Clinics, Radiopharmacies, Academic Institutions, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alpha Emitter Market will witness a strong CAGR of 13.7% , valued at $990 million in 2024 , and is projected to grow significantly to reach around $2.15 billion by... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Erythropoietin Drugs Market By Drug Class (Epoetin Alfa, Darbepoetin Alfa, Epoetin Beta, Others); By Application (Chronic Kidney Disease, Cancer, HIV, Surgical Procedures, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erythropoietin Drugs Market will witness a robust CAGR of 8.2% , valued at $ 11.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Inhalable Drugs Market by Product Type (MDIs, DPIs, Nebulizers); By Application (Asthma, COPD, Other Respiratory Disorders); By End-User (Hospitals, Clinics, Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inhalable Drugs Market will witness a robust CAGR of 6.3% , valued at $20.5 billion in 2024 , expected to appreciate and reach $3... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485

Corticosteroids Market By Product Type (Systemic Corticosteroids, Topical Corticosteroids, Inhaled Corticosteroids, Ophthalmic Corticosteroids, Intranasal Corticosteroids); By Route of Administration (Oral, Parenteral, Topical, Inhaled, Ophthalmic, Intranasal); By Application (Respiratory Diseases, Dermatological Disorders, Autoimmune & Inflammatory Disorders, Ophthalmic Conditions, Endocrine Disorders, Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Corticosteroids Market will witness a robust CAGR of 6.74 % , valued at $16.2 billion in 2024, expected to appreciate and reach $21.4 billionRead More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

PARP Inhibitor Market By Drug Type (Olaparib, Niraparib, Rucaparib, Talazoparib, Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PARP Inhibitor Market will witness a sustained CAGR of 12.6% , valued at $5.1 billion in 2024 , and is expected to appreciate and reach <... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Antihypertensive Drugs Market By Product Type (ACE Inhibitors, Calcium Channel Blockers, Diuretics, Beta-blockers, ARBs); By Therapeutic Class (Monotherapy, Combination Therapy); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Antihypertensive Drugs Market will experience a steady growth trajectory from 2024 to 2030, driven by the increasing prevalence of hypertension globally, especially among aging populations. The global market for ... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Microneedle Flu Vaccine Market By Product Type (Solid, Dissolving, Coated, Hollow); By Route of Administration (Transdermal, Intradermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Vaccination Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microneedle Flu Vaccine Market will witness a robust CAGR of 18.4% , valued at $516 million in 2024 , expected to appreciate and reach $1.43 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:152 | $ 4485

Diphenhydramine Market By Product Type (Branded, Generic); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diphenhydramine Market is projected to expand steadily between 2024 and 2030, growing at a Cagr Of 5.8% . Valued at around USD 350 Million In 2024... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Angina Pectoris Drugs Market By Drug Class (Nitrates, Beta-Blockers, Calcium Channel Blockers, Antiplatelet Agents, Ranolazine and Novel Anti-Anginals); By Route of Administration (Oral, Intravenous, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Angina Pectoris Drugs Market will witness a robust CAGR of 5.7% , valued at $9.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Myelodysplastic Syndrome Drugs Market By Drug Class (Hypomethylating Agents, Immunomodulatory Drugs, Targeted Therapies, Supportive Care Drugs); By Route of Administration (Oral, Injectable); By End User (Hospitals, Oncology Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myelodysplastic Syndrome (MDS) Drugs Market will witness a robust CAGR of 10.1% , valued at USD 2.1 billion in 2... Read More

Published Date: OCT-2025 | No Of Pages:179 | $ 4485

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Methicillin-Resistant Staphylococcus Aureus Drugs Market By Drug Class (Glycopeptides, Oxazolidinones, Lipopeptides, Cephalosporins, Tetracyclines, Others); By Route of Administration (Oral, Parenteral, Topical); By Indication (Skin and Soft Tissue Infections, Bloodstream Infections, Pneumonia, Bone and Joint Infections, Others); By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutions, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market will witness a promising CAGR of 6.4 % ... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Immune Checkpoint Inhibitors Market By Drug Type (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, Others); By Cancer Type (Lung, Melanoma, Bladder, Breast, Liver, Others); By End User (Hospitals & Cancer Centers, Academic Institutes, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Immune Checkpoint Inhibitors Market will witness a robust CAGR of 13.8% , valued at $42.3 billion in 2024 , and is expected to appreciate and reach $102.1 billion ... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485

Empty Capsules Market By Capsule Type (Gelatin, Vegetarian, Others); By End-User Application (Pharmaceutical, Nutraceutical, Cosmetic); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Empty Capsules Market will witness a robust CAGR of 5.6% , valued at USD 5.6 billion in 2024 , expected to appreciate and reach U... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Plasma Protease C1-Inhibitor Market By Product Type (Plasma-Derived C1-Inhibitor, Recombinant C1-Inhibitor); By Route of Administration (Intravenous, Subcutaneous); By Indication (Hereditary Angioedema, Acquired Angioedema, Other Complement Disorders); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Plasma Protease C1 -Inhibitor Market will witness a robust CAGR of 7.4% , valued at USD 1.14 billion in 2024 , and is expected to appreci... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

HPV Associated Disorders Market By Product Type (Prophylactic Vaccines, Therapeutic Vaccines, Diagnostic Assays, Topical and Systemic Treatments); By Indication (Cervical Cancer, Genital Warts, Oropharyngeal Cancers, Recurrent Respiratory Papillomatosis); By End User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Public Health Agencies & NGOs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global HPV Associated Disorders Market will witness a robust CAGR of 7.2% , valued at USD 4.8 billion in 2024 , expected to appreciate and reach USD 7.8 ... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Postpartum Depression Drugs Market By Drug Class (Selective Serotonin Reuptake Inhibitors, Neuroactive Steroids, Tricyclic Antidepressants, Atypical Antidepressants, Others); By Route of Administration (Oral, Intravenous, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postpartum Depression (PPD) Drugs Market will witness a robust CAGR of 28.6% , valued at $1.72 billion in 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485